Tackling Low Medication Supplies
and Disruptions in the Supply Chain
Amidst the COVID-19 Pandemic
Greater emphasis on technology and a drive for innovation
In times of urgency, technology can be leveraged in new or enhanced ways to improve access and efficiency, partner with diverse stakeholders, and generate greater information. Innovation is fundamental. Evaluate how the institution thinks about adaptability, agility, and flexibility within the supply chain.
Engaging diverse stakeholders
No one operates in a silo – so, what does that mean moving forward? The pharmaceutical supply chain includes numerous diverse stakeholders. The questions will continue to be: what can organizations or regulatory bodies require of each in the supply chain, and how does one regulate or enforce such a strategy? How can all the different stakeholders work together to ensure a reliable, safe, quality drug supply chain? Leveraging expertise, perspectives, innovation & technology from various disciplines is integral to addressing these medication issues.
The issue and the solution to accessing medications is multidisciplinary. Management of drug shortages requires a collaborative effort by different professionals within health facilities and across industries and countries. Continue to seek insight from the different professionals often impacted by disruptions in supplies within the health facilities in order to assess the practical on-the-ground efforts by institutions to manage drug shortages. Create new partnerships to tackle the issue, whether it is institution-specific, community-based, or nationally. Identify not only each stakeholder incentives but our collective incentives as well. There is a need to support one another. Does it take something as substantial as a pandemic to create such a collective incentive structure?
Information is constantly evolving in the healthcare space. Responsible effort was made to provide accurate information from reliable sources at the time of publication. Information provided in the articles and website is done so in good faith; however, no liabilities for the information (such as errors or omission) exist. The reader should make their own assessment and determination of how they will use the information provided. The author and publisher provide no guarantees of any specific outcome or consequence as a result of utilizing recommendations or information offered in this article. Readers are advised to continuously check the latest updates, practices and guidelines.
Your comment will be posted after it is approved.
Leave a Reply.
Dr. Rola Kaakeh
CEO, Salus Vitae Group